Hong Kong Stocks Movement | CRO Concept Stocks Plunge Collectively: GENSCRIPT BIO (01548) Drops Over 6%, PHARMARON (03759) Falls Over 4%

Stock News11-21

CRO concept stocks experienced a collective decline in Hong Kong trading. As of press time, GENSCRIPT BIO (01548) dropped 6.05% to HKD 14.92, while PHARMARON (03759) fell 4.67% to HKD 20.8. VIVA BIOTECH (01873) declined 4.57% to HKD 1.88, and TIGERMED (03347) slid 3.71% to HKD 36.9.

The market movement followed stronger-than-expected US non-farm payroll data for September released overnight. Post-data, swap contracts continued to reflect shrinking expectations for a Fed rate cut in December.

Analysts note that while overseas CPI data has shown fluctuations in 2024, global markets may gradually enter a rate-cutting cycle. Expectations for improved investment and financing conditions are strengthening, with some companies already seeing order recovery. The sector is anticipated to benefit from valuation recovery opportunities, particularly for overseas CRO/CDMO and domestic preclinical CRO services.

Despite significant impacts from domestic and international investment environments, the CRO sector is expected to gradually recover as domestic policies take effect. Clinical CRO investment opportunities remain a key focus for sustained recovery.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1150686106?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-21 14:52","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1150686106","market":"sh","top_or_hot":-1,"title":"Hong Kong Stocks Movement | CRO Concept Stocks Plunge Collectively: GENSCRIPT BIO (01548) Drops Over 6%, PHARMARON (03759) Falls Over 4%","media":"Stock News","content":"<p>CRO concept stocks experienced a collective decline in Hong Kong trading. As of press time, GENSCRIPT BIO (01548) dropped 6.05% to HKD 14.92, while PHARMARON (03759) fell 4.67% to HKD 20.8. VIVA BIOTECH (01873) declined 4.57% to HKD 1.88, and TIGERMED (03347) slid 3.71% to HKD 36.9.</p>\n<p>The market movement followed stronger-than-expected US non-farm payroll data for September released overnight. Post-data, swap contracts continued to reflect shrinking expectations for a Fed rate cut in December.</p>\n<p>Analysts note that while overseas CPI data has shown fluctuations in 2024, global markets may gradually enter a rate-cutting cycle. Expectations for improved investment and financing conditions are strengthening, with some companies already seeing order recovery. The sector is anticipated to benefit from valuation recovery opportunities, particularly for overseas CRO/CDMO and domestic preclinical CRO services.</p>\n<p>Despite significant impacts from domestic and international investment environments, the CRO sector is expected to gradually recover as domestic policies take effect. Clinical CRO investment opportunities remain a key focus for sustained recovery.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Hong Kong Stocks Movement | CRO Concept Stocks Plunge Collectively: GENSCRIPT BIO (01548) Drops Over 6%, PHARMARON (03759) Falls Over 4%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nHong Kong Stocks Movement | CRO Concept Stocks Plunge Collectively: GENSCRIPT BIO (01548) Drops Over 6%, PHARMARON (03759) Falls Over 4%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2025-11-21 14:52</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>CRO concept stocks experienced a collective decline in Hong Kong trading. As of press time, GENSCRIPT BIO (01548) dropped 6.05% to HKD 14.92, while PHARMARON (03759) fell 4.67% to HKD 20.8. VIVA BIOTECH (01873) declined 4.57% to HKD 1.88, and TIGERMED (03347) slid 3.71% to HKD 36.9.</p>\n<p>The market movement followed stronger-than-expected US non-farm payroll data for September released overnight. Post-data, swap contracts continued to reflect shrinking expectations for a Fed rate cut in December.</p>\n<p>Analysts note that while overseas CPI data has shown fluctuations in 2024, global markets may gradually enter a rate-cutting cycle. Expectations for improved investment and financing conditions are strengthening, with some companies already seeing order recovery. The sector is anticipated to benefit from valuation recovery opportunities, particularly for overseas CRO/CDMO and domestic preclinical CRO services.</p>\n<p>Despite significant impacts from domestic and international investment environments, the CRO sector is expected to gradually recover as domestic policies take effect. Clinical CRO investment opportunities remain a key focus for sustained recovery.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1150686106","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1150686106","pubTimestamp":1763707934,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"CRO concept stocks experienced a collective decline in Hong Kong trading. As of press time, GENSCRIPT BIO (01548) dropped 6.05% to HKD 14.92, while PHARMARON (03759) fell 4.67% to HKD 20.8. VIVA...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"300759":"康龙化成","03759":"康龙化成","BK0216":"研究试验","01873":"维亚生物","BK1141":"生命科学工具和服务","01548":"金斯瑞生物科技","HK0000320223.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) ACC","BK1576":"医药外包概念","BK1583":"高瓴概念","HK0000320264.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) ACC","HK0000306701.USD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (USD) INC","HK0000306685.HKD":"TAIKANG KAITAI CHINA NEW OPPORTUNITIES FUND \"A\" (HKD) INC","03347":"泰格医药"},"translate_title":"港股动向|CRO概念股集体暴跌：金斯瑞生物(01548)跌超6%康龙化成(03759)跌超4%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"300759":1,"03347":1,"01548":1,"03759":1,"01873":1},"content_text":"CRO concept stocks experienced a collective decline in Hong Kong trading. As of press time, GENSCRIPT BIO (01548) dropped 6.05% to HKD 14.92, while PHARMARON (03759) fell 4.67% to HKD 20.8. VIVA BIOTECH (01873) declined 4.57% to HKD 1.88, and TIGERMED (03347) slid 3.71% to HKD 36.9.\nThe market movement followed stronger-than-expected US non-farm payroll data for September released overnight. Post-data, swap contracts continued to reflect shrinking expectations for a Fed rate cut in December.\nAnalysts note that while overseas CPI data has shown fluctuations in 2024, global markets may gradually enter a rate-cutting cycle. Expectations for improved investment and financing conditions are strengthening, with some companies already seeing order recovery. The sector is anticipated to benefit from valuation recovery opportunities, particularly for overseas CRO/CDMO and domestic preclinical CRO services.\nDespite significant impacts from domestic and international investment environments, the CRO sector is expected to gradually recover as domestic policies take effect. Clinical CRO investment opportunities remain a key focus for sustained recovery.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.10","shortVersion":"4.35.10","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1150686106","isCrawlerRequest":true}